Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
                32%
                                OVERLAP
BY WEIGHT
18
                                # OF OVERLAPPING
HOLDINGS
PBE
                            28
                                HOLDINGS
                            
                                    64%
                                
                                ALSO IN BBP
                            BBP
                            57
                                HOLDINGS
                            
                                    30%
                                
                                ALSO IN PBE
                            SECTOR DRIFT (PBE minus BBP)
                OVERLAPPING HOLDINGS
                Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE  | 
                                Weight in BBP  | 
                                Overlap | |
|---|---|---|---|---|
| IONIS PHARMACEUTICALS, INC. | 4.2% | 2.7% | 2.7% | |
| HALOZYME THERAPEUTICS INC | 2.4% | 2.6% | 2.4% | |
| MADRIGAL PHARMACEUTICALS, INC. | 2.7% | 2.4% | 2.4% | |
| ACADIA PHARMACEUTICALS INC | 2.2% | 2.4% | 2.2% | |
| GILEAD SCIENCES INC | 4.6% | 2.1% | 2.1% | |
PBE Overweight Relative to BBP
                | ILLUMINA INC | 4.8% | |
| ROYALTY PHARMA PLC CLASS A | 4.7% | |
| BIOGEN IDEC INC | 4.0% | |
| REGENERON PHARMACEUTICALS | 3.5% | |
| VERTEX PHARMACEUTICALS INC | 3.5% | |
| VERACYTE INC | 3.2% | |
| EXACT SCIENCES CORP | 3.1% | |
| AMGEN INC | 3.1% | |
| SAREPTA THERAPEUTICS INC | 2.9% | |
| INCYTE CORP | 2.8% | 
PBE Underweight Relative to BBP
                | INSMED INC | -3.3% | |
| BRIDGEBIO PHARMA, INC. | -3.2% | |
| ALNYLAM PHARMACEUTICALS INC | -3.0% | |
| RHYTHM PHARMACEUTICALS, INC. | -3.0% | |
| MIRUM PHARMACEUTICALS, INC. | -3.0% | |
| BEIGENE LTD. SPONSORED ADR | -2.9% | |
| INTRA-CELLULAR THERAPIES INC | -2.6% | |
| ASCENDIS PHARMA A/S | -2.6% | |
| PHATHOM PHARMACEUTICALS, INC. | -2.5% | |
| SAGE THERAPEUTICS INC | -2.5% |